Literature DB >> 28623451

Neighborhood Inequalities in Hepatitis C Mortality: Spatial and Temporal Patterns and Associated Factors.

Mary M Ford1, Payal S Desai2, Gil Maduro3, Fabienne Laraque4.   

Abstract

Deaths attributable to hepatitis C (HCV) infection are increasing in the USA even as highly effective treatments become available. Neighborhood-level inequalities create barriers to care and treatment for many vulnerable populations. We seek to characterize citywide trends in HCV mortality rates over time and identify and describe neighborhoods in New York City (NYC) with disproportionately high rates and associated factors. We used a multiple cause of death (MCOD) definition for HCV mortality. Cases identified between January 1, 2006, and December 31, 2014, were geocoded to NYC census tracts (CT). We calculated age-adjusted HCV mortality rates and identified spatial clustering using a local Moran's I test. Temporal trends were analyzed using joinpoint regression. A multistep global and local Poisson modeling approach was used to test for neighborhood associations with sociodemographic indicators. During the study period, 3697 HCV-related deaths occurred in NYC, with an average annual percent increase of 2.6% (p = 0.02). The HCV mortality rates ranged from 0 to 373.6 per 100,000 by CT, and cluster analysis identified significant clustering of HCV mortality (I = 0.23). Regression identified positive associations between HCV mortality and the proportion of non-Hispanic black or Hispanic residents, neighborhood poverty, education, and non-English-speaking households. Local regression estimates identified spatially varying patterns in these associations. The rates of HCV mortality in NYC are increasing and vary by neighborhood. HCV mortality is associated with many indicators of geographic inequality. Results identified neighborhoods in greatest need for place-based interventions to address social determinants that may perpetuate inequalities in HCV mortality.

Entities:  

Keywords:  Communicable diseases; Disease modeling; Hepatitis; Mortality; Spatial analysis

Mesh:

Year:  2017        PMID: 28623451      PMCID: PMC5610126          DOI: 10.1007/s11524-017-0174-x

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  29 in total

1.  Permutation tests for joinpoint regression with applications to cancer rates.

Authors:  H J Kim; M P Fay; E J Feuer; D N Midthune
Journal:  Stat Med       Date:  2000-02-15       Impact factor: 2.373

Review 2.  Invited commentary: Advancing theory and methods for multilevel models of residential neighborhoods and health.

Authors:  Patricia O'Campo
Journal:  Am J Epidemiol       Date:  2003-01-01       Impact factor: 4.897

3.  Hepatitis B and C virus infection among 1.2 million persons with access to care: factors associated with testing and infection prevalence.

Authors:  Philip R Spradling; Loralee Rupp; Anne C Moorman; Mei Lu; Eyasu H Teshale; Stuart C Gordon; Cynthia Nakasato; Joseph A Boscarino; Emily M Henkle; David R Nerenz; Maxine M Denniston; Scott D Holmberg
Journal:  Clin Infect Dis       Date:  2012-08-08       Impact factor: 9.079

4.  Using GIS-based density maps of HIV surveillance data to identify previously unrecognized geographic foci of HIV burden in an urban epidemic.

Authors:  Colin W Shepard; Heidi W Gortakowski; Hani Nasrallah; Blayne H Cutler; Elizabeth M Begier
Journal:  Public Health Rep       Date:  2011 Sep-Oct       Impact factor: 2.792

5.  Disparities in Reportable Communicable Disease Incidence by Census Tract-Level Poverty, New York City, 2006-2013.

Authors:  Sharon K Greene; Alison Levin-Rector; James L Hadler; Annie D Fine
Journal:  Am J Public Health       Date:  2015-07-16       Impact factor: 9.308

6.  Hepatitis C elimination by 2030 through treatment and prevention: think global, act in local networks.

Authors:  M Hellard; R Sacks-Davis; J Doyle
Journal:  J Epidemiol Community Health       Date:  2016-06-24       Impact factor: 3.710

7.  Late diagnosis of hepatitis C virus infection in the Chronic Hepatitis Cohort Study (CHeCS): Missed opportunities for intervention.

Authors:  Anne C Moorman; Jian Xing; Stephen Ko; Loralee B Rupp; Fujie Xu; Stuart C Gordon; Mei Lu; Philip R Spradling; Eyasu H Teshale; Joseph A Boscarino; Vinutha Vijayadeva; Mark A Schmidt; Scott D Holmberg
Journal:  Hepatology       Date:  2015-03-20       Impact factor: 17.425

8.  The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007.

Authors:  Kathleen N Ly; Jian Xing; R Monina Klevens; Ruth B Jiles; John W Ward; Scott D Holmberg
Journal:  Ann Intern Med       Date:  2012-02-21       Impact factor: 25.391

9.  HIV and hepatitis C mortality in Massachusetts, 2002-2011: spatial cluster and trend analysis of HIV and HCV using multiple cause of death.

Authors:  David J Meyers; Maria Elena Hood; Thomas J Stopka
Journal:  PLoS One       Date:  2014-12-11       Impact factor: 3.240

10.  National trends in hospitalization and mortality rates for patients with HIV, HCV, or HIV/HCV coinfection from 1996-2010 in the United States: a cross-sectional study.

Authors:  Christine U Oramasionwu; Joshua C Toliver; Terence L Johnson; Heather N Moore; Christopher R Frei
Journal:  BMC Infect Dis       Date:  2014-10-10       Impact factor: 3.090

View more
  7 in total

1.  Challenges of Treating an Acute Hepatitis C Virus Infection With Concurrent Seizure Treatment in a Free Clinic.

Authors:  Nicholas Blackmond; Joshua D Kanke; Tiffany Loh; Raymond Weitzman
Journal:  Cureus       Date:  2022-05-31

2.  Concurrent Hepatitis C and B Virus and Human Immunodeficiency Virus Infections Are Associated With Higher Mortality Risk Illustrating the Impact of Syndemics on Health Outcomes.

Authors:  Zahid A Butt; Stanley Wong; Carmine Rossi; Mawuena Binka; Jason Wong; Amanda Yu; Maryam Darvishian; Maria Alvarez; Nuria Chapinal; Geoff Mckee; Mark Gilbert; Mark W Tyndall; Mel Krajden; Naveed Z Janjua
Journal:  Open Forum Infect Dis       Date:  2020-08-13       Impact factor: 3.835

3.  Urban Green Space Is Spatially Associated with Cardiovascular Disease Occurrence in Women of Mashhad: a Spatial Analysis of Influential Factors on their Presence in Urban Green Spaces.

Authors:  Mohammad Rahim Rahnama; Lia Shaddel
Journal:  J Urban Health       Date:  2019-10       Impact factor: 3.671

4.  Metropolitan age-specific mortality trends at borough and neighborhood level: The case of Mexico City.

Authors:  Karol Baca-López; Cristóbal Fresno; Jesús Espinal-Enríquez; Miriam V Flores-Merino; Miguel A Camacho-López; Enrique Hernández-Lemus
Journal:  PLoS One       Date:  2021-01-19       Impact factor: 3.240

5.  Predictors of hepatitis C treatment outcomes in a harm reduction-focused primary care program in New York City.

Authors:  Jacob Ziff; Trang Vu; Danielle Dvir; Farah Riazi; Wilma Toribio; Scott Oster; Keith Sigel; Jeffrey Weiss
Journal:  Harm Reduct J       Date:  2021-03-31

6.  Patient characteristics and neighborhood attributes associated with hepatitis C screening and positivity in Philadelphia.

Authors:  Dong Heun Lee; Edgar Y Chou; Kari Moore; Steven Melly; Yuzhe Zhao; Hal Chen; James W Buehler
Journal:  Prev Med Rep       Date:  2022-10-03

7.  Independent Risk Factors for Hepatocellular Carcinoma Recurrence after Direct-Acting Antiviral Therapy in Patients with Chronic Hepatitis C.

Authors:  Young-Hwan Ahn; Heirim Lee; Do Young Kim; Hye Won Lee; Su Jong Yu; Young Youn Cho; Jeong Won Jang; Byoung Kuk Jang; Chang Wook Kim; Hee Yeon Kim; Hana Park; Hyo Jung Cho; Bumhee Park; Soon Sun Kim; Jae Youn Cheong
Journal:  Gut Liver       Date:  2021-05-15       Impact factor: 4.519

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.